In this segment, Dr. Gregory Vidal discusses when biomarker testing is performed during the treatment journey for ER-positive ...

In this segment, Dr. Gregory Vidal explains why it is essential for patients to understand their hormone receptor status and HER2 status when diagnosed with ER-positive, HER2-negative metastatic ...

Pyrotinib in the first-line treatment of HER2-positive advanced breast cancer: Results from the PRETTY study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

HER2-positive breast cancer is a type of breast cancer that grows and spreads quickly. If you have HER2-positive breast cancer, it means your cancer cells contain high levels of a protein called human ...

HER2 — which stands for human epidermal growth factor receptor 2 — is a type of protein that causes cancer cells to grow more quickly. Tumors that are HER2-positive have higher levels of the HER2 ...

If you have HER2-positive breast cancer, your options for treatment will depend on several factors, such as the stage of cancer (early or metastatic) and the hormone receptor status of the tumor. HER2 ...

– Approval is based on Phase III INAVO120 results, showing the Itovebi TM (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. "We ...